Category Archives: Biotech

GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases

Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 — /EPR Network/ — R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

The GenQual proprietary real-time PCR platform, when applied to the genes that are involved in the manifestation of several autoimmune diseases, allows us to detect and assess single nucleotide polymorphisms. Here, allelic determination is used as potential predictor of the treatment response by the novel anti-IL6 antibody, which is currently in development by R-Pharm.

more…

BOC Sciences Released Analytical Support Services

Long Island City, New York, January 15, 2016 — /EPR NETWORK/ — Thursday of this week (January 14, 2016), BOC Sciences officially launched its analytical support service, aiming to provide all-round custom services on the base of its present services in pharmaceutical field.

BOC SCIENCES LOGO

The analytical service of BOC Sciences covers a wide range in almost every aspect of drug discovery from impurities identification, purity level testing, to right equipment suggestion for compound preparation with the aim of providing the best solutions for research conduction and maximizing the outcome with less waste in both time and cost.

more…

Regenexx Announces the Publication of “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” on Amazon Kindle

Released on: February 02, 2015, 4:33 am (EST)
Author: Dr. Chris Centeno
Industry: Biotech, Healthcare

Broomfield, CO, February 02, 2015 — /EPR NETWORK/ — With more than 40,000 downloads, “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” is now available on Amazon Kindle. The third edition of the top-selling e-book is being offered as a free download through Jan. 6, 2015.

Written by Dr. Chris Centeno, this e-book delves into the human musculoskeletal system and explains how everything works together in concert to maintain our physical wellbeing. When a single component in this chain is damaged, it can lead to a cascade of joint, spine and connective tissue problems, resulting in chronic pain.

more…

ViroCarb’s anti HIV Crowd Funding Campaign

Released on: December 01, 2014, 2:30 pm (EST)
Author: ViroCarb Inc.
Industry: Biotech, Healthcare, Pharmaceuticals

Toronto, Canada, December 01, 2014 — /EPR NETWORK/ — ViroCarb Inc. has launched a worldwide crowd funding campaign to promote the development of its new HIV infection inhibitor.

WORLD AIDS DAY – Make a donation to save lives from AIDS! Support new treatment development at: https://www.indiegogo.com/projects/funding-a-new-therapy-against-drug-resistant-hiv/x/9240077

Despite the great progress made in HIV/AIDS treatment, there is still an urgent need for new drugs, particularly for people who have had to abandon existing treatments due to HIV drug resistance and side effects.

more…

HD Biosciences, Co., Ltd. and E. J. Corey Institute of Biomedical Research Reached Agreement for Drug R&D Collaboration  

Released on: May 28, 2014, 5:11 pm (EDT)
Author: HD Biosciences Co.,Ltd. 
Industry: PharmaceuticalsBiotech

Shanghai, May 28, 2014 — /EPR NETWORK/ — HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.

more…

Axcellerate Pharma, New Jersey aims to become a market leader in high-value, niche offerings to the US life sciences industry

Released on: November 20, 2013, 1:10 pm
Author: TCG Lifesciences Limited
Industry: Biotech

November 20, 2013, 1:10 pm — /EPR NETWORK/ — Axcellerate Pharma establishes CMO/CRO and API manufacturing facility in New Jersey, US. Focus will be small molecule and biologics PR&D, innovative technology platforms, filling vial and bag operations, peptide synthesis, oligonucleotide production and related areas.

more…

HD Biosciences and Anchor Therapeutics Form Collaboration for Co-marketing Pepducin-mediated GPCR Technology

Released on: October 28, 2013, 10:18 am
Author: HD Biosciences 
Industry: BiotechPharmaceuticals

October 28, 2013, 10:18 am — /EPR NETWORK/ — HD Biosciences Co., Ltd (HDB) and Anchor Therapeutics, Inc. today announced that they have formed a strategic collaboration to co-develop and co-market Anchor’s proprietary pepducin technology and provide novel drug development solutions to global pharmaceutical companies with drug discovery efforts focused on G-protein coupled receptors (GPCR).

more…

LC Sciences Launches Online Searchable Knowledgebase

Released on: October 08, 2013, 12:48 am
Author: LC Sciences
Industry: BiotechInternet & Online

Houston, TX, October 08, 2013, 12:48 am — /EPR NETWORK/ — LC Sciences, LLC, a leading provider of microRNA analysis services, today announced the launch of a new online searchable knowledgebase that researchers can use to locate technical information on the company’s website. This announcement comes on the heels of the launch of LC Sciences’ re-designed company website last week. The knowledgebase contains technical information in the form of application notes, technical bulletins, customer publications, presentations, reviews of seminal publications in the field, etc. This documents database contains over one thousand entries and encompasses a wide range of research fields; from plant science to neuroscience. Additionally, all entries have been carefully meta-tagged to improve search results.

more…

Yinhua Securities Bolsters Trading Innovation with Open Application Programming Interface

Released on: December 24, 2012, 9:29 am
Author: Financial World News 
Industry: Financial

December 24, 2012, 9:29 am — /EPR NETWORK/ — Yinhua Securities’s Trading, Data and Account Management Technology Now Accessible via Open Application Programming Interface, Allowing Traders and Software Developers to Create Innovative New Investing Applications

more…

Microtissues® Inc. and Sigma-Aldrich® Sign Worldwide Supply and Distribution Agreement for the 3D Petri Dish®

Released on: December 11, 2012, 9:54 am
Author: Microtissues Inc. 
Industry: BiotechPharmaceuticals

PROVIDENCE, Rhode Island, December 11, 2012, 9:54 am — /EPR NETWORK/ — Microtissues® Inc. announced today the signing of a Supply and Distribution Agreement with Sigma-Aldrich® Corporation (Nasdaq: SIAL) for the worldwide sales and marketing of the 3D Petri Dish®, a new technology for the culture of living cells in three dimensions (3D). Invented at Brown University, the 3D Petri Dish® maximizes cell-to-cell interactions critical for replicating the function of natural tissues and organs. Shown in numerous peer reviewed papers to work with over fifty different cell types, including cell lines, primary cells and stem cells, the 3D Petri Dish® has applications in cancer research, drug discovery, toxicity testing and regenerative medicine.

more…